Deakin University
Browse

File(s) not publicly available

Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines

Version 2 2024-06-13, 09:18
Version 1 2015-08-20, 13:51
conference contribution
posted on 2024-06-13, 09:18 authored by K McDonald, K Nozue-Okada, M Khasraw
Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines

History

Volume

74

Location

San Diego, Calif.

Start date

2014-04-05

End date

2014-04-09

ISSN

0008-5472

eISSN

1538-7445

Language

English

Publication classification

E3.1 Extract of paper

Title of proceedings

Proceedings of the AACR Annual Meeting 2014

Event

American Association for Cancer Research. Conference (2014 : San Diego, Calif.)

Issue

19

Publisher

American Association for Cancer Research